Time: 7.30 a.m. to 10 a.m. EST
Location: The Rotman School of Management, U of Toronto, 105 St. George Street, Toronto
Fee: CORE Members: complimentary. Non-members please go to the Rotman site to register.
This joint Rotman Institute for International Business and CORE forum will focus on ‘Creation and Innovation’. Bringing two case studies from the creative and pharmaceutical industries, it will focus on learning more about how innovation can be achieved as well as how to effectively manage the significant IP issues that arise, such as copyright and patents. It will be of interest to both seasoned outsourcing professionals, and managers wanting to learn more about outsourcing, innovation and how to deal with IP issues when outsourcing. The forum will be interactive with open Q & A discussion. Participants will have an opportunity to learn from both the speakers as well as from the interaction with the broader audience assembled.
Featured Speakers
Kevin O’Brien Fehr, Ph.D.
Director, R&D Alliances GlaxoSmithKline Inc.
Kevin O’Brien Fehr is a pharmacologist who received her PhD at the University of Toronto in 1977. After working for ten years at the Addiction Research Foundation of Ontario as a scientist and educator, she joined the staff of the Medical Liaison Service of Sandoz Canada. There, she spent five years acting as an interface between the company and the Canadian medical research community in the areas of psychiatry and neurology. Since 1992, Kevin has managed basic research and genetics studies conducted in Canadian companies and universities on behalf of GlaxoSmithKline. She has extensive contacts in the academic and biotechnology communities throughout the country, and is actively working to attract funding from GlaxoSmithKline’s international sources for the support of Canadian researchers. She serves, or has served in an advisory capacity on several Boards of Directors including the AllerGen NCE and the Canada Foundation for Innovation.
Norm Bolen
President/CEO of the Canadian Film & Television Production Association (CFTPA)
Norm Bolen is currently the President and CEO of the Canadian Film and Television Production Association (CFTPA), based in Ottawa. The CFTPA represents Canada’s independent film, television and interactive producers. Norm is the former Executive Vice President, Content, for Alliance Atlantis Communications. At Alliance Atlantis he had overall programming responsibility for thirteen Canadian specialty networks: Showcase, History Television, Slice, HGTV, Food Network Canada, BBC Canada, BBC Kids, Discovery Health Channel, National Geographic Channel, Independent Film Channel, Showcase Action, Showcase Diva and Fine Living Television. Norm was also responsible for Alliance Atlantis' web based and emerging new media content and all Broadcast Operations. Prior to joining Alliance Atlantis in 1997, Norm spent 21 years at the Canadian Broadcasting Corporation as a journalist and executive. In his last position at the CBC he was the head of Network Television Current Affairs. In that role, he had overall responsibility for CBC Television’s Documentary Department. Norm is a current Board member and past Chair of the Banff World Television Festival and the Hot Docs International Documentary Festival, a Director of the National Screen Institute and a Director of the ACTRA Fraternal Benefit Society. Until recently, he was also a Director of mDialog, a web-based high-resolution video distribution platform that's optimized for the iPhone.
Eileen McMahon
Partner, Torys LLP
Eileen is the co-chair of Torys' Intellectual Property and Food and Drug Regulatory Practice. She is one of a handful of Canadian lawyers who advise on regulatory clearance and intellectual property protection of products in Canada. Eileen is recognized nationally and internationally as a leading cross-border practitioner in the areas of commercial agreements and licensing in the life sciences industry (drugs, medical devices, biologics, dietary supplements and natural health products). Her expertise spans commercial agreements, outsourcing, regulatory, intellectual property. She has been recognized in Chambers Global, Which Lawyer? Yearbook, Lexpert Guide to the Leading 500 Lawyers in Canada and Best Lawyers in Canada. She co-leads a course on healthcare licensing and strategic alliances (accredited by the Canadian Healthcare Licensing Association and endorsed by the Toronto Biotechnology Initiative). She co-leads a workshop on commercial contracts for Federated Press. Eileen sits on the boards of various drug and biotechnology companies, and various industry and intellectual property associations.
Register now for this event
